Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Cao, Nan  [Clear All Filters]
Journal Article
Ma T, Li J, Xu Y, Yu C, Xu T, Wang H, Liu K, Cao N, Nie B-M, Zhu S-Y, et al. Atg5-independent autophagy regulates mitochondrial clearance and is essential for iPSC reprogramming. Nat Cell Biol. 2015.
Zhang X, Zhao M, Cao N, Qin W, Zhao M, Wu J, Lin D. Construction of a tumor microenvironment pH-responsive cleavable PEGylated hyaluronic acid nano-drug delivery system for colorectal cancer treatment. Biomater Sci. 2020.
Liu C, Hu X, Li Y, Lu W, Li W, Cao N, Zhu S, Cheng J, Ding S, Zhang M. Conversion of mouse fibroblasts into oligodendrocyte progenitor-like cells through a chemical approach. J Mol Cell Biol. 2019.
Zhang Y, Cao N, Huang Y, C Spencer I, Fu J-D, Yu C, Liu K, Nie B, Xu T, Li K, et al. Expandable Cardiovascular Progenitor Cells Reprogrammed from Fibroblasts. Cell Stem Cell. 2016;18(3):368-381.
Wang L, Liu S, Li K, Ma A, Hu C, Wang C, Cao N, Zhao Y, Fu R, Jia W, et al. General requirements for the production of extracellular vesicles derived from human stem cells. Cell Prolif. 2023:e13554.
Wang J, Wang Q, Cao N. Generation of expandable cardiovascular progenitor cells from mouse and human fibroblasts via direct chemical reprogramming. STAR Protoc. 2022;3(4):101908.
Han Z, Yu Y, Xu J, Bao Z, Xu Z, Hu J, Yu M, Bamba D, Ma W, Ding F, et al. Iron Homeostasis Determines Fate of Human Pluripotent Stem Cells Via Glycerophospholipids-Epigenetic Circuit. Stem Cells. 2018.
Tang S, Xie M, Cao N, Ding S. Patient-specific Induced Pluripotent Stem Cells for Disease Modeling and Phenotypic Drug Discovery. J Med Chem. 2015.
Ji X, Chen Z, Wang Q, Li B, Wei Y, Li Y, Lin J, Cheng W, Guo Y, Wu S, et al. Sphingolipid metabolism controls mammalian heart regeneration. Cell Metab. 2024.